spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  diabetic foot ulcers 

 HSMN NewsFeed - 16 Jun 2023
VIVEX Biologics, Inc. Launches New CYGNUS(R) Dual Amniotic Allograft
Devices Wound Care Product Launch
 HSMN NewsFeed - 11 May 2022
Acera Surgical Announces Michael Finegan as New CEO
Devices Surgery Wound Care Personnel
 HSMN NewsFeed - 6 Apr 2022
MolecuLight i:X(R) Receives Regulatory Clearance and Reimbursement in South Korea
Devices Wound Care Regulatory
 HSMN NewsFeed - 14 Feb 2022
Advanced Oxygen Therapy: Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
Devices Wound Care Personnel
 HSMN NewsFeed - 19 May 2021
SoftWave Tissue Regeneration Technologies Receives FDA Clearance for Blood Circulation Increase, Minor Aches and Pains Relief and Connective Tissue Activation
Devices FDA
 HSMN NewsFeed - 10 Nov 2020
MicroVascular Tissues Reports Positive Results for HIFLO Trial Demonstrating Increased Closure and High Quality of Healing Using mVASC(R) Microvascular Tissue Graft
Regenerative Medicine Wound Care
 HSMN NewsFeed - 3 Jun 2019
PolarityTE Creates Office of the Chief Executive to Focus on Commercialization and Operational Performance
Regenerative Medicine Personnel
 HSMN NewsFeed - 10 May 2019
PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE
Regenerative Medicine Wound Care
 HSMN NewsFeed - 20 Feb 2019
ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy
Regenerative Medicine
 HSMN NewsFeed - 28 Nov 2018
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
Devices Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 28 Sep 2018
LYNCH Biologics Closes on Transaction to Purchase GEM 21S(R) Growth Factor Enhanced Matrix for Dental Bone Regeneration
Devices Biopharmaceuticals Dental Acquisitions
 HSMN NewsFeed - 28 Sep 2018
EO2 Announces Positive Results from Two Recent Studies: Double-Blind Randomized Study Evaluates Continuous Diffusion of Oxygen in Patients with Chronic Wounds & Second Pilot Study Builds on Growing Body of Clinical Evidence for the EO2 O2 Delivery System
Devices Wound Care
 HSMN NewsFeed - 14 Feb 2018
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
Devices Wound Care
 HSMN NewsFeed - 13 Feb 2018
SANUWAVE Announces Strategic Partnership With Premier Shockwave
Devices Wound Care
 HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology
 HSMN NewsFeed - 21 Nov 2017
MiMedx Provides Update On Its Reimbursement Coverage
Regenerative Medicine Reimbursement
 HSMN NewsFeed - 31 Aug 2017
MiMedx Reports MultiCenter randomized Controlled VLU Clinical Study Accepted for Publication in The International Wound Journal
Biopharmaceuticals Regenerative Medicine Wound Care
 HSMN NewsFeed - 3 Aug 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 27 Apr 2017
SANUWAVE Announces Cooperation With Ortho-Medico in Europe and Exhibition at EWMA -- Visit Us at Booth Number 3 E14
Devices Wound Care Distribution
 HSMN NewsFeed - 6 Mar 2017
Izun Pharmaceuticals Announces Approval of Curasite(TM) Hydrogel Wound Care Product by FDA
Biopharmaceuticals Wound Care FDA
 HSMN NewsFeed - 20 Jan 2017
Osiris Therapeutics announced a Comparative Effectiveness Study on the Use of Two Human Placental Membranes in Wound Management is Available Electronically in a Peer-Reviewed Journal
Devices Wound Care
 HSMN NewsFeed - 12 Jan 2017
Derma Sciences Buys MEDIHONEY(R) Brand From Long-Term Partner
Regenerative Medicine Wound Care Acquisitions
 HSMN NewsFeed - 28 Dec 2016
NanoVibronix Receives Health Canada Approval to Sell WoundShield(TM) in Canada
Devices Wound Care Regulatory
 HSMN NewsFeed - 8 Nov 2016
BRH Medical Receives Patents in Both the USA and in China for Its Innovative Wound Healing Therapy
Devices Wound Care
 HSMN NewsFeed - 18 Aug 2016
Derma Sciences Names Russell Olsen President of Advanced Wound Care
Regenerative Medicine Wound Care Dermatology Personnel
 HSMN NewsFeed - 21 Dec 2015
Derma Sciences Announces Leadership and CEO Transition
Devices Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 19 Nov 2015
AMNIOX Highlights Study Showing Eighty Percent of Patients With Lower-extremity Ulcers Achieve Healing When Treated with NEOX(R) Wound Allograft
Devices Wound Care
 HSMN NewsFeed - 15 Jun 2015
Innocoll AG Announces First Patient Dosed in the Cogenzia COACT-2 Phase 3 Study for the Treatment of Diabetic Foot Infection
Devices Wound Care
 HSMN NewsFeed - 5 Nov 2014
U.S. Veterans And Military Gain Access To "Smart" Wound Care Technology
Devices Wound Care Distribution
 HSMN NewsFeed - 29 Jul 2014
AMNIOX(R) Medical Announces Initiation of Prospective, Randomized, Controlled Clinical Study of Chronic Wounds
Regenerative Medicine Wound Care
 HSMN NewsFeed - 24 Jun 2014
NeuroMetrix Reports Japan Regulatory Approval for NC-stat DPNCheck
Devices Regulatory
 HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jun 2014
Tissue Regenix Announces Launch of DermaPure(TM) in the USA
Devices Regenerative Medicine Wound Care Product Launch
 HSMN NewsFeed - 25 Apr 2014
KCI Presents New Clinical and Economic Evidence at SAWC/WHS Spring 2014 Conference
Devices Wound Care
 HSMN NewsFeed - 24 Apr 2014
Grafix(R) Pharmacoeconomic and Scientific Characterization Studies Featured at the 2014 Spring Symposium for Advanced Wound Care
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 17 Jan 2014
Organogenesis Inc. Announces Acquisition of Dermagraft(R) from Shire
Devices Wound Care Acquisitions
 HSMN NewsFeed - 17 Jan 2014
Shire Executes Agreement to Divest DERMAGRAFT(R)
Devices Wound Care Acquisitions
 HSMN NewsFeed - 14 Jan 2014
Derma Sciences Enters the Skin Substitute Market with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products
Devices Wound Care Licensing
 HSMN NewsFeed - 23 Dec 2013
Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 12 Dec 2013
MiMedx Receives Additional Medicare Reimbursement Coverage for EpiFix(R)
Devices Regenerative Medicine Wound Care Reimbursement
 HSMN NewsFeed - 28 Oct 2013
APR Applied Pharma Research (APR) announces the European CE approval for Nexodyn(R), a newly developed product for the management of acute and chronic wounds
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 5 Sep 2013
ULURU Inc. Extends The International Altrazeal(R) License To Include Additional Territories
Devices Wound Care Licensing
 HSMN NewsFeed - 4 Sep 2013
SANUWAVE Appoints Life Sciences Industry Executive, Alan L. Rubino To Its Board
Devices Wound Care Personnel
 HSMN NewsFeed - 13 Aug 2013
Alliqua Signs Distribution Agreement with Team Distributing International and World Health Industries for SilverSeal(R) and Hydress(R) Wound Dressings
Devices Wound Care Distribution
 HSMN NewsFeed - 1 Mar 2013
Osiris Therapeutics Establishes Direct Sales Force for Grafix(R)
Devices Regenerative Medicine Wound Care Distribution
 HSMN NewsFeed - 26 Feb 2013
SANUWAVE Health Announces the Appointment of CEO and Closing of its $2.0 Million Bridge Financing
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Feb 2013
Graftjacket(R) Regenerative Tissue Matrix Receives Medicare Reimbursement in Ten Northwestern States
Devices Wound Care Reimbursement
 HSMN NewsFeed - 23 Jan 2013
IYIA Technologies Announces New Treatment Option for Foot Ulcers and Other Wounds That Won’t Heal
Devices Wound Care
 HSMN NewsFeed - 15 Nov 2012
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Sep 2012
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 6 Sep 2012
Derma Sciences Launches MEDIHONEY(R) HCS in the U.S.
Devices Wound Care
 HSMN NewsFeed - 5 Sep 2012
DERMAGRAFT(R) Approved in Canada for Treatment of Diabetic Foot Ulcers
Devices Wound Care Regulatory
 HSMN NewsFeed - 30 Aug 2012
KCI Leads Educational Effort to Improve Patient Care Worldwide
Devices Wound Care
 HSMN NewsFeed - 13 Jul 2012
Derma Sciences Acquires Global Long-Term Exclusive Rights to NIMBUS Technology from Quick-Med Technologies
Devices Wound Care Licensing
 HSMN NewsFeed - 10 Jul 2012
Derma Sciences Receives CE Mark for MEDIHONEY(R) HCS
Devices Wound Care Regulatory
 HSMN NewsFeed - 26 Jun 2012
Spiracur Announces New SNaP Bridge Dressing for Plantar Surface Wound Care
Devices Wound Care
 HSMN NewsFeed - 13 Jun 2012
Stratatech’s StrataGraft(R) Skin Substitute Granted FDA Orphan Drug Designation
Devices Biopharmaceuticals Regenerative Medicine FDA
 HSMN NewsFeed - 8 May 2012
SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE
Devices Wound Care FDA
 HSMN NewsFeed - 2 May 2012
Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device
Devices Interventional FDA
 HSMN NewsFeed - 2 May 2012
The KCI Graftjacket(R) Regenerative Tissue Matrix Reimbursed by Medicare in Eight Midwestern States
Devices Wound Care Reimbursement
 HSMN NewsFeed - 19 Apr 2012
Covalon to Feature New Advanced Wound Care Products at the Symposium on Advanced Wound Care in Atlanta
Devices Wound Care
 HSMN NewsFeed - 17 Apr 2012
Organogenesis Inc. Announces Major Milestones in Improved Apligraf(R) Reimbursement and Access to Care for Patients Suffering from Chronic Wounds
Devices Wound Care Reimbursement
 HSMN NewsFeed - 17 Apr 2012
Derma Sciences Completes MedEfficiency Acquisition
Devices Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2012
Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™
Biopharmaceuticals Wound Care Distribution
 HSMN NewsFeed - 29 Mar 2012
Derma Sciences to Acquire MedEfficiency; Expands Proprietary Advanced Wound Care Product Offering with High-Growth, Market-Leading, Gold-Standard Treatment for Diabetic Foot Ulcers
Devices Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2012
ULURU Inc. Completes Altrazeal(R) License Agreement for Europe
Devices Wound Care Licensing
 HSMN NewsFeed - 5 Jan 2012
Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen(TM) in South Korea
Devices Wound Care Distribution
 HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Devices Distribution
 HSMN NewsFeed - 27 Oct 2011
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Devices Surgery Regulatory
 HSMN NewsFeed - 2 Aug 2011
Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans
Devices Wound Care FDA
 HSMN NewsFeed - 20 Jul 2011
Agennix Hires Christine Boisclair as Senior Vice President of Global Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2011
SANUWAVE Announces American Medical Association Approval of CPT Category III Codes for Extracorporeal Shock Wave Technology in Wound Healing
Devices Wound Care Reimbursement
 HSMN NewsFeed - 14 Jul 2011
HealOr Names Dr. Michael L. Sabolinski, M.D. as New CEO
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 22 Jun 2011
Agennix Hires Jill Porter as Senior Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2011
Healthpoint Biotherapeutics Acquires Regranex(R) Gel
Biopharmaceuticals Wound Care Acquisitions
 HSMN NewsFeed - 18 Apr 2011
CoDa Therapeutics Closes $19 Million Series B Financing Round
Biopharmaceuticals Wound Care Venture Capital
 HSMN NewsFeed - 13 Apr 2011
Devon Medical Products Receives FDA 510(k) Clearance for ArterioFlow(TM) Pump that Treats Diabetic Foot, Peripheral Arterial Disorders
Devices FDA
 HSMN NewsFeed - 8 Mar 2011
Positive Findings From Excellagen Matrix Clinical Study Published in Peer-Reviewed Journal Wound Repair and Regeneration
Devices Wound Care Regenerative Medicine
 HSMN NewsFeed - 31 Jan 2011
KCI Licenses Wright Medical’s GRAFTJACKET(R) Brand for Wound Care
Devices Wound Care Regenerative Medicine Licensing
 HSMN NewsFeed - 13 Dec 2010
New Dermagraft Coding to Streamline Reimbursement Process for Medicare Providers
Devices Wound Care Reimbursement
 HSMN NewsFeed - 10 Dec 2010
Advanced BioHealing Appoints Kevin C. O'Boyle as Chief Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Jun 2010
Derma Sciences Receives CE Mark for ALGICELL(R) Ag
Devices Wound Care Regulatory
 HSMN NewsFeed - 28 May 2010
KCI Announces FDA Clearance of V.A.C.(R) Therapy for Venous Insufficiency Ulcers
Devices Wound Care
 HSMN NewsFeed - 26 May 2010
Organogenesis Announces Symposium for the Treatment of Chronic Wounds at EWMA Annual Conference in Switzerland
Regenerative Medicine Wound Care
 HSMN NewsFeed - 4 May 2010
Derma Sciences Launches XTRASORB(TM) Foam Wound Dressing
Devices Wound Care
 HSMN NewsFeed - 10 Mar 2010
SANUWAVE Health's Technology Shown to Successfully Treat Nonunion Fractures of the Tibia
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 20 Jan 2010
SANUWAVE Appoints Dr. Maria Siemionow of Cleveland Clinic to Its Scientific Advisory Board
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Jan 2010
Cardium to Launch MedPodium(TM) Product Line Initially Covering Six New Advanced Foot Care Products for Podiatry Patients to Complement the Excellagen Platform
Devices Wound Care
 HSMN NewsFeed - 15 Dec 2009
EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution
Devices Wound Care FDA
 HSMN NewsFeed - 3 Dec 2009
Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Devices Wound Care FDA
 HSMN NewsFeed - 2 Nov 2009
Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
Devices Wound Care
 HSMN NewsFeed - 15 Oct 2009
Positive Findings from Excellarate(TM) Phase 1/2 Clinical Study Published in Journal of Wound Repair and Regeneration
Devices Biopharmaceuticals Wound Care
 HSMN NewsFeed - 24 Aug 2009
New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing
Devices Wound Care Radiology
 HSMN NewsFeed - 30 Jul 2009
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 28 Jul 2009
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
Regenerative Medicine Wound Care
 HSMN NewsFeed - 14 May 2009
ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber
Devices Wound Care
 HSMN NewsFeed - 7 May 2009
Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 22 Apr 2009
Surgeons Utilize Collagen Bioscaffolds to Treat Diabetic Ulcers, Save Limbs
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 31 Mar 2009
Cardium's InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapy's Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
Devices Neurosurgery
 HSMN NewsFeed - 31 Mar 2009
Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
Devices Wound Care
 HSMN NewsFeed - 9 Mar 2009
KCI Introduces new V.A.C.(R) GranuFoam(TM) Bridge Dressing
Devices Wound Care
 HSMN NewsFeed - 9 Mar 2009
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Devices Urology Oncology
 HSMN NewsFeed - 29 Jan 2009
Safeguard Scientifics Joins $10.4 Million Financing of Garnet Biotherapeutics
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 22 Jan 2009
ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
Devices Surgery Wound Care FDA
 HSMN NewsFeed - 7 Jan 2009
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
Devices FDA
 HSMN NewsFeed - 16 Dec 2008
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Devices Urology
 HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing
 HSMN NewsFeed - 17 Nov 2008
Innocoll Receives Fast Track Designation for Gentamicin Surgical Implant
Devices Drug Delivery FDA
 HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Devices Urology
 HSMN NewsFeed - 28 Oct 2008
Study Shows Celleration's MIST Therapy(R) Expedites Wound Healing
Devices Wound Care
 HSMN NewsFeed - 23 Oct 2008
NanoVibronix Receives FDA Clearance for its PainShield(TM) MD Device
Devices FDA
 HSMN NewsFeed - 22 Oct 2008
Oculus Innovative Sciences Launches Microcyn(R) Wound Care for U.S. Podiatry Market
Devices Wound Care
 HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA
 HSMN NewsFeed - 22 Sep 2008
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2008
Derma Sciences Announces Latest Exclusive Technology Distribution Agreement
Devices Wound Care Distribution
 HSMN NewsFeed - 25 Aug 2008
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory
 HSMN NewsFeed - 9 Jun 2008
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery
 HSMN NewsFeed - 23 Apr 2008
Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 21 Apr 2008
BioMimetic Therapeutics Receives Written Communication from FDA Confirming Status of Ongoing Pivotal Trial for GEM OS1
Devices Orthopaedic
 HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology
 HSMN NewsFeed - 28 Mar 2008
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution
 HSMN NewsFeed - 17 Mar 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 27 Feb 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 25 Feb 2008
Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2008
Final Study Results Show V.A.C.(R) Therapy to be More Efficacious Than Advanced Moist Wound Therapy in Treating Diabetic Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 11 Feb 2008
Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 9 Jan 2008
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
Regenerative Medicine Wound Care
 HSMN NewsFeed - 4 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Devices Surgery Pain Management
 HSMN NewsFeed - 3 Jan 2008
Oculus Innovative Sciences Completes Patient Treatment and Follow-up in Its Phase II Clinical Trial in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 2 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Devices Surgery
 HSMN NewsFeed - 18 Dec 2007
Oculus Innovative Sciences Announces Completion of Two Randomized Controlled Clinical Trials of Microcyn(R) Technology in China
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 18 Dec 2007
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 17 Dec 2007
CytRx Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2007
Pegasus Biologics Receives CE Mark for Diabetic Foot Ulcer Treatment
Devices Wound Care Regulatory
 HSMN NewsFeed - 13 Dec 2007
Integra LifeSciences Launches Flowable Wound Matrix
Devices Wound Care
 HSMN NewsFeed - 11 Dec 2007
Organogenesis, Inc. Signs Memorandum of Understanding with Chinese Regenerative Medicine Company
Devices Wound Care Regenerative Medicine
 HSMN NewsFeed - 14 Nov 2007
Cardium and InnerCool Complete $5 Million Commercial Financing to Support Launch of New Product Lines
Devices
 HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 17 Oct 2007
Innocoll Files Investigational New Drug Application for its CollaRx(R) BUPIVACAINE TOPICAL for the Treatment of Painful Chronic Skin Ulcers and Burns
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 3 Oct 2007
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Sep 2007
CytRx Provides Arimoclomol and Iroxanadine Clinical Trial Updates
Biopharmaceuticals Neurology Wound Care
 HSMN NewsFeed - 17 Sep 2007
Oculus Innovative Sciences Provides Update of Phase II Study for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 12 Sep 2007
CytRx Names Mitchell K. Fogelman Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2007
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 6 Sep 2007
CytRx Subsidiary RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2007
Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Biopharmaceuticals Surgery Acquisitions
 HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Jul 2007
Ortec International: Dr. Costa Papastephanou Appointed CEO
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 27 Jun 2007
CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Jun 2007
Cytomedix Announces CMS to Reconsider Coverage for Platelet Rich Plasma Technology
Devices Wound Care Reimbursement
 HSMN NewsFeed - 26 Jun 2007
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Dmitry Samarsky, Ph.D., as Vice President of Technology Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2007
Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
Devices Regenerative Medicine
 HSMN NewsFeed - 18 Jun 2007
Oculus Innovative Sciences Appoints Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2007
CoMentis Receives FDA Clearance to Begin Human Clinical Trials for Its Disease-Modifying Alzheimer's Therapy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Jun 2007
CoMentis Announces Appointment of Martin Tolar, M.D., Ph.D., as Vice President of Strategic and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2007
Innocoll Announces Filing of Investigational New Drug Application for its CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Jun 2007
Survival Benefit Demonstrated in Placebo-Controlled Trial in Patients with Refractory Non-Small Cell Lung Cancer Treated with Agennix's Oral Talactoferrin
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2007
Advanced BioHealing Closes Second Tranche of Series C Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 1 May 2007
KCI Announces Positive Results From Clinical Study Utilizing V.A.C.(R) Therapy in the Treatment of Diabetic Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 24 Apr 2007
Innocoll Announces Outcome of FDA Meeting to Commence Phase 3 Development of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Devices Surgery FDA
 HSMN NewsFeed - 18 Apr 2007
Cytomedix Provides Update On FDA Review
Devices Wound Care FDA
 HSMN NewsFeed - 10 Apr 2007
CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology
 HSMN NewsFeed - 19 Mar 2007
Smith & Nephew Announces Worldwide Agreement With Covalon Technologies
Devices Wound Care Distribution
 HSMN NewsFeed - 26 Feb 2007
Ortec Initiates Premarket Approval (PMA) Application Filing Seeking Approval for OrCel(R) in Treating Venous Leg Ulcers
Regenerative Medicine Wound Care FDA
 HSMN NewsFeed - 20 Feb 2007
Athenagen Announces Name Change to CoMentis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Feb 2007
Advanced BioHealing Enrolls First Patient in Celaderm(TM) Pilot Venous Leg Ulcer Clinical Trial
Regenerative Medicine Wound Care
 HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Devices
 HSMN NewsFeed - 22 Jan 2007
Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers with Its CollaRx(R) GENTAMICIN
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Nov 2006
Cardium Announces Formation of Scientific Advisory Board
Devices Personnel
 HSMN NewsFeed - 13 Nov 2006
Treatment of Diabetic Foot Ulcers to Be Addressed at Upcoming American Heart Association Meeting
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 9 Nov 2006
Innocoll Announces Investigational New Drug Application Filing for its CollaRx GENTAMICIN as a Topical Treatment for Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Oct 2006
Diabetes-Associated Nerve and Circulatory Damage Is the Leading Cause of Lower Limb Amputations
Devices Wound Care
 HSMN NewsFeed - 12 Oct 2006
Agennix Receives FDA Orphan Drug Designation for Talactoferrin Alfa in Renal Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Oct 2006
Agennix Receives FDA Fast Track Designation for Talactoferrin Alfa in Non-Small Cell Lung Cancer and Diabetic Foot Ulcers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter to Ortec for Use of Cryopreserved OrCel(R) in Epidermolysis Bullosa Patients' Hand Reconstructions and Donor Sites
Regenerative Medicine FDA
 HSMN NewsFeed - 28 Sep 2006
Athenagen Raises $50 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 21 Sep 2006
Dr. Michael Morgan Reports on Benefits of InnerCool's Celsius Control System in Inducing Hypothermia During Aneurysm Surgery
Devices Neurosurgery
 HSMN NewsFeed - 12 Sep 2006
Ortec Announces Positive Results in Confirmatory Venous Leg Ulcer Trial
Devices Wound Care Regenerative Medicine
 HSMN NewsFeed - 17 Jul 2006
Cambrex and Ortec Submit to FDA a Humanitarian Device Exemption (HDE) for OrCel(R) to Treat Epidermolysis Bullosa Patients
Devices
 HSMN NewsFeed - 6 Jul 2006
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
Regenerative Medicine
 HSMN NewsFeed - 31 May 2006
Advanced BioHealing Announces Purchase of Dermagraft(R) and TransCyte(R)
Devices Wound Care Acquisitions
 HSMN NewsFeed - 8 May 2006
Athenagen Announces the Appointment of John Donovan as Chief Financial Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 58

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 58 additional stories matching:
diabetic foot ulcers
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.